{"title":"慢性炎症性脱髓鞘性多根神经病变的历史:疾病概念的建立、变化和治疗的未来。","authors":"Takashi Kanda","doi":"10.11477/mf.188160960770010015","DOIUrl":null,"url":null,"abstract":"<p><p>The year 2025 marks the 50th anniversary of the publication of the first paper by Dr. P.J. Dyck that uses the disease name \"chronic inflammatory polyradiculoneuropathy (CIP)\". By combining chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), which was previously termed using miscellaneous names, into a single disease concept, a major step forward was made in its diagnosis and treatment. In this paper, we first address the establishment of the disease concept, its acceptance in Japan, and the transition and current status of treatment methods. However, CIDP treatment has not yet been developed to provide satisfactory results for all patients. In the second half of this paper, we discuss therapeutic prospects of the near future based on possible pathological mechanisms.</p>","PeriodicalId":52507,"journal":{"name":"Brain and Nerve","volume":"77 1","pages":"15-27"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[History of Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Establishment of Disease Concepts, Changes, and the Future of Treatment].\",\"authors\":\"Takashi Kanda\",\"doi\":\"10.11477/mf.188160960770010015\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The year 2025 marks the 50th anniversary of the publication of the first paper by Dr. P.J. Dyck that uses the disease name \\\"chronic inflammatory polyradiculoneuropathy (CIP)\\\". By combining chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), which was previously termed using miscellaneous names, into a single disease concept, a major step forward was made in its diagnosis and treatment. In this paper, we first address the establishment of the disease concept, its acceptance in Japan, and the transition and current status of treatment methods. However, CIDP treatment has not yet been developed to provide satisfactory results for all patients. In the second half of this paper, we discuss therapeutic prospects of the near future based on possible pathological mechanisms.</p>\",\"PeriodicalId\":52507,\"journal\":{\"name\":\"Brain and Nerve\",\"volume\":\"77 1\",\"pages\":\"15-27\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Brain and Nerve\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.11477/mf.188160960770010015\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Brain and Nerve","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.11477/mf.188160960770010015","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
[History of Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Establishment of Disease Concepts, Changes, and the Future of Treatment].
The year 2025 marks the 50th anniversary of the publication of the first paper by Dr. P.J. Dyck that uses the disease name "chronic inflammatory polyradiculoneuropathy (CIP)". By combining chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), which was previously termed using miscellaneous names, into a single disease concept, a major step forward was made in its diagnosis and treatment. In this paper, we first address the establishment of the disease concept, its acceptance in Japan, and the transition and current status of treatment methods. However, CIDP treatment has not yet been developed to provide satisfactory results for all patients. In the second half of this paper, we discuss therapeutic prospects of the near future based on possible pathological mechanisms.